Literature DB >> 3938155

Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation.

E A Loeliger.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3938155     DOI： 10.1159/000206187

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  10 in total

1.  Evaluation of Time in Therapeutic Range (TTR) in Patients with Non-Valvular Atrial Fibrillation Receiving Treatment with Warfarin in Tehran, Iran: A Cross-Sectional Study.

Authors:  Bahram-Fariborz Farsad; Mohammad Abbasinazari; Atousa Dabagh; Hooman Bakshandeh
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Frequency of attendance at anticoagulant clinics: a prospective study.

Authors:  M R Howard; D W Milligan
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

Review 3.  Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.

Authors:  E A Loeliger
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

4.  The effects of lower intensity anticoagulation therapy on coagulation system in patients with mechanical prosthetic valves.

Authors:  X Du; K Zhang; Z Hu; H Lan; J Luo; Y Jin
Journal:  J Tongji Med Univ       Date:  1999

5.  Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.

Authors:  L Schmitt; J Speckman; J Ansell
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

6.  Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation.

Authors:  Susan I O'Shea; Murat O Arcasoy; Gregory Samsa; Sandra E Cummings; Elizabeth H Thames; Richard S Surwit; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2007-07-08       Impact factor: 2.300

7.  Monitoring prothrombin fragment 1 + 2 during initiation of oral anticoagulant therapy after intracoronary stenting.

Authors:  G Hafner; H Swars; R Erbel; W Ehrenthal; H J Rupprecht; J Lotz; J Meyer; W Prellwitz
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

Review 8.  Determinants and measures of quality in oral anticoagulation therapy.

Authors:  Scott Kaatz
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

Review 9.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10

Review 10.  Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.

Authors:  Petra M G Erkens; Hugo ten Cate; Harry R Büller; Martin H Prins
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.